Navigation Links
Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration
Date:6/6/2013

Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional liver cells.

"The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy," said the study's senior author, Valerie Gouon-Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sinai. "Until now, liver transplantation has been the most successful treatment for people with liver failure, but we have a drastic shortage of organs. This discovery may help circumvent that problem."

In conjunction with the laboratory of Matthew J. Evans, PhD, from the Department of Microbiology at Icahn School of Medicine at Mount Sinai, investigators demonstrated the functionality of the liver cells generated from the progenitors, as the liver cells can be infected by the hepatitis C virus, a property restricted to liver cells exclusively.

A critical discovery in this research was finding that the novel progenitor has a receptor protein on its cell surface called KDR, or vascular endothelial growth factor receptor 2, which until now, was thought to be restricted to endothelial cells that form vessels, the progenitors for endothelial cells and the progenitors blood cells. The research team showed that activation of KDR on these novel liver progenitors differentiates them into mature liver cells. Additionally, work in a mouse model revealed similar cells, indicating that the progenitors are conserved from mouse to human, and therefore, they must be "important cells with promising potential for cell therapy in treating liver disease," explained Dr. Gouon-Evans.

Next, the research team will examine specifically whether these liver cells obtained from human embryonic stem cells in a dish help repair injured livers in preclinical animal models of liver disease.


'/>"/>

Contact: Renatt Brodsky
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related biology news :

1. Going green: Nation equipped to grow serious amounts of pond scum for fuel
2. Intermountain Medical Center reseachers develop new 3-D technology to treat atrial fibrillation
3. Mount Sinai Selects Exemplar LIMS for Genomics Core Facility
4. The right amount of vitamin D for babies
5. Mount Sinai study identifies new gene variations associated with heart rate
6. Mount Sinai leads global program using stem cells to accelerate cures for Alzheimers disease
7. Intermountain study finds length of DNA strands can predict life expectancy
8. Antibacterial agent used in common soaps found in increasing amounts in freshwater lakes
9. Evidence mounts for role of mutated genes in development of schizophrenia
10. Mount Sinai grad student, 25, named to Forbes 30 Under 30 in Science and Healthcare
11. New book details the biological and cultural diversity of Khawa Karpo, sacred mountain of Tibet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:4/21/2017)... ... April 21, 2017 , ... The 2017 ... categories with over 30 nominees and well as the first-year award for 2017 ... and the event was hosted by CompanyWeek and Manufacturers Edge, among other sponsors. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... today announced first round funding to three startups through the UConn Innovation Fund. ... to new business startups affiliated with UConn. , The UConn Innovation Fund provides ...
(Date:4/21/2017)... Muncie, IN (PRWEB) , ... April 21, 2017 , ... ... year to 11 high school graduates from across the nation. The scholarships are created ... of AMA member dues. , Scholarship criteria are set by the AMA Scholarship Committee, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick Innovative Technology Center, ... emerging technology-based businesses, recently earned a $77,518 grant from the Rural Maryland Council ... 2004, FITCI is Frederick’s first incubator. A non-profit corporation, FITCI is a public-private ...
Breaking Biology Technology: